Ann Arbor, MI
HistoSonics® is developing a non-invasive, robotically assisted platform capable of destroying tissue at a sub-cellular level.
histosonics.comThese are collections HistoSonics is a part of. Click on the collection name to view similar companies.
Private Equity
$250,000,000
Series D
$102,000,000
Convertible Note
$85,000,000
Debt Financing
$15,000,000
Series C
$40,000,000
Series C
$54,700,000
Series Unknown
$4,825,000
Series B
$8,260,313
Debt Financing
$3,500,000
Debt Financing
$1,500,000
Series A
$14,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on HistoSonics.